Going Beyond Host Defence Peptides: Horizons of Chemically Engineered Peptides for Multidrug-Resistant Bacteria.

Cavallazzi Sebold, Bernardo; Li, Junjie; Ni, Guoying; Fu, Quanlan; Li, Hejie; Liu, Xiaosong; Wang, Tianfang

Cavallazzi Sebold, Bernardo; Li, Junjie; Ni, Guoying; Fu, Quanlan; Li, Hejie; Liu, Xiaosong; Wang, Tianfang.

Afiliación

Cavallazzi Sebold B; Centre for Bioinnovation, University of the Sunshine Coast, Maroochydore BC, QLD, 4558, Australia.
Li J; School of Science, Engineering and Technology, University of the Sunshine Coast, Maroochydore BC, QLD, 4558, Australia.
Ni G; The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, 510080, Guangdong, China.
Fu Q; Centre for Bioinnovation, University of the Sunshine Coast, Maroochydore BC, QLD, 4558, Australia.
Li H; The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, 510080, Guangdong, China.
Liu X; Cancer Research Institute, First People's Hospital of Foshan, Foshan, 528000, Guangdong, China.
Wang T; The First Affiliated Hospital/Clinical Medical School, Guangdong Pharmaceutical University, Guangzhou, 510080, Guangdong, China.

BioDrugs ; 37(5): 607-623, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37300748

Asunto(s)

Péptidos Catiónicos Antimicrobianos; Enterococcus faecium; Humanos; Klebsiella pneumoniae; Enterobacter; Pseudomonas aeruginosa; Antibacterianos/farmacología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enterococcus faecium / Péptidos Catiónicos Antimicrobianos Límite: Humans Idioma: En Revista: BioDrugs Asunto de la revista: ALERGIA E IMUNOLOGIA / GENETICA MEDICA / TERAPEUTICA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google